1. Home
  2. LXRX vs CMRC Comparison

LXRX vs CMRC Comparison

Compare LXRX & CMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • CMRC
  • Stock Information
  • Founded
  • LXRX 1995
  • CMRC 2009
  • Country
  • LXRX United States
  • CMRC United States
  • Employees
  • LXRX N/A
  • CMRC N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • CMRC
  • Sector
  • LXRX Health Care
  • CMRC
  • Exchange
  • LXRX Nasdaq
  • CMRC Nasdaq
  • Market Cap
  • LXRX 428.8M
  • CMRC 391.6M
  • IPO Year
  • LXRX 2000
  • CMRC 2020
  • Fundamental
  • Price
  • LXRX $1.09
  • CMRC $4.96
  • Analyst Decision
  • LXRX Buy
  • CMRC Strong Buy
  • Analyst Count
  • LXRX 5
  • CMRC 1
  • Target Price
  • LXRX $3.23
  • CMRC $10.00
  • AVG Volume (30 Days)
  • LXRX 1.6M
  • CMRC 797.8K
  • Earning Date
  • LXRX 11-11-2025
  • CMRC 11-06-2025
  • Dividend Yield
  • LXRX N/A
  • CMRC N/A
  • EPS Growth
  • LXRX N/A
  • CMRC N/A
  • EPS
  • LXRX N/A
  • CMRC N/A
  • Revenue
  • LXRX $58,432,000.00
  • CMRC $337,541,000.00
  • Revenue This Year
  • LXRX N/A
  • CMRC $5.25
  • Revenue Next Year
  • LXRX N/A
  • CMRC $4.67
  • P/E Ratio
  • LXRX N/A
  • CMRC N/A
  • Revenue Growth
  • LXRX 1504.83
  • CMRC 4.06
  • 52 Week Low
  • LXRX $0.28
  • CMRC $4.14
  • 52 Week High
  • LXRX $2.18
  • CMRC $7.99
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 47.78
  • CMRC N/A
  • Support Level
  • LXRX $1.03
  • CMRC N/A
  • Resistance Level
  • LXRX $1.19
  • CMRC N/A
  • Average True Range (ATR)
  • LXRX 0.06
  • CMRC 0.00
  • MACD
  • LXRX -0.00
  • CMRC 0.00
  • Stochastic Oscillator
  • LXRX 35.29
  • CMRC 0.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About CMRC Commerce.com Inc. Series 1 Common Stock

Commerce.com Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of its revenue is generated from Americas-U.S.

Share on Social Networks: